SciClone Pharmaceuticals (Holdings) Limited

SHSC:6600 Rapporto sulle azioni

Cap. di mercato: HK$11.4b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

SciClone Pharmaceuticals (Holdings) Gestione

Gestione criteri di controllo 3/4

We currently do not have sufficient information about the CEO.

Informazioni chiave

Hong Zhao

Amministratore delegato

CN¥17.0m

Compenso totale

Percentuale dello stipendio del CEO45.0%
Mandato del CEO4yrs
Proprietà del CEO0.2%
Durata media del management2yrs
Durata media del Consiglio di amministrazione3.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Hong Zhao rispetto agli utili di SciClone Pharmaceuticals (Holdings)?
DataCompenso totaleStipendioGuadagni aziendali
Dec 31 2023n/an/a

CN¥1b

Sep 30 2023n/an/a

CN¥1b

Jun 30 2023n/an/a

CN¥953m

Mar 31 2023n/an/a

CN¥904m

Dec 31 2022CN¥17mCN¥8m

CN¥855m

Sep 30 2022n/an/a

CN¥844m

Jun 30 2022n/an/a

CN¥833m

Mar 31 2022n/an/a

CN¥878m

Dec 31 2021CN¥26mCN¥7m

CN¥923m

Sep 30 2021n/an/a

CN¥837m

Jun 30 2021n/an/a

CN¥779m

Mar 31 2021n/an/a

CN¥766m

Dec 31 2020CN¥29mCN¥7m

CN¥754m

Sep 30 2020n/an/a

CN¥817m

Dec 31 2019CN¥15mCN¥6m

CN¥615m

Compensazione vs Mercato: Hong's total compensation ($USD2.35M) is above average for companies of similar size in the Hong Kong market ($USD480.51K).

Compensazione vs guadagni: Hong's compensation has been consistent with company performance over the past year.

AMMINISTRATORE DELEGATO

Hong Zhao (61 yo)

4yrs

Mandato

CN¥17,030,000

Compensazione

Mr. Hong Zhao has been President and Chief Executive Officer at SciClone Pharmaceuticals (Holdings) Limited since June 24, 2020 and also serves as its Executive Director since June 24, 2020. Mr. Zhao serve...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Hong Zhao
CEO, President & Executive Director4yrsCN¥17.03m0.18%
HK$ 20.6m
Rongrong Pan
Company Secretaryless than a yearNessun dato0.026%
HK$ 3.0m
Chihwen Shao
VP & Head of Technical Operations and Pharmacovigilance2.4yrsNessun datoNessun dato
Min Jia
VP & Head of Immunization Business Unitno dataNessun datoNessun dato
Mingxiang Wu
VP and Head of Market Access & Commercial Operation (MACO) Departmentno dataNessun datoNessun dato
Lianzong Wu
VP and Head of Registration & Pharmaceutical Affairs Departmentno dataNessun datoNessun dato
Li Mao
VP, GM of Research and Development & Chief Medical Officer2yrsNessun datoNessun dato
Min Wu
VP & Chief Business Development Officerless than a yearNessun datoNessun dato

2.0yrs

Durata media

55yo

Età media

Gestione esperta: 6600's management team is considered experienced (2 years average tenure).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Hong Zhao
CEO, President & Executive Director4yrsCN¥17.03m0.18%
HK$ 20.6m
Rongrong Pan
Company Secretary1.1yrsNessun dato0.026%
HK$ 3.0m
Daniel Vasella
Non-Executive Director3.8yrsCN¥658.00kNessun dato
Guoen Liu
Independent Non-Executive Director3.3yrsCN¥658.00kNessun dato
Zhenfu Li
Non-Executive Chairman4yrsNessun datoNessun dato
Wendy Hayes
Independent Non-Executive Director3.3yrsCN¥658.00kNessun dato
Haixia Wang
Non-Executive Director3yrsNessun datoNessun dato
Yi-Hsien Lin
Non-Executive Director3.3yrsNessun datoNessun dato
Ping Chen
Independent Non-Executive Director3.3yrsCN¥658.00kNessun dato
Yushao Gu
Independent Non-Executive Director3.3yrsCN¥658.00kNessun dato

3.3yrs

Durata media

58yo

Età media

Consiglio di amministrazione esperto: 6600's board of directors are considered experienced (3.3 years average tenure).